(Q43538629)

24 November 2017

In vitro antibiotic susceptibilities of Borrelia isolates from erythema migrans lesion of Lyme disease patients in Japan (English)

1 reference

24 November 2017

0 references

Masuzawa T

1

1 reference

24 November 2017

Yamada K

series ordinal

2

1 reference

24 November 2017

Kawabata H

series ordinal

3

1 reference

24 November 2017

Yanagihara Y

series ordinal

4

1 reference

24 November 2017

1 January 1994

1 reference

Microbiology and Immunology

24 November 2017

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

24 November 2017

38

1 reference

24 November 2017

5

1 reference

24 November 2017

399-402

1 reference

In vitro susceptibilities of Borrelia burgdorferi to five oral cephalosporins and ceftriaxone

24 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1994.TB01798.X

Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1994.TB01798.X

Clinical and microbiologic findings in six patients with erythema migrans of Lyme disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1994.TB01798.X

Lyme disease-a tick-borne spirochetosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1994.TB01798.X

Monoclonal antibodies for identification of Borrelia afzelii sp. nov. associated with late cutaneous manifestations of Lyme borreliosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1994.TB01798.X

In vitro activity of vancomycin against the spirochete Borrelia burgdorferi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1994.TB01798.X

Borrelia burgdorferi sp. nov.: Etiologic Agent of Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1994.TB01798.X

In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1994.TB01798.X

Comparative in vitro and in vivo susceptibilities of the Lyme disease spirochete Borrelia burgdorferi to cefuroxime and other antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1994.TB01798.X

Genomic analysis of Borrelia japonica sp. nov. isolated from Ixodes ovatus in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1994.TB01798.X

Immunological Properties ofBorrelia burgdorferiIsolated from theIxodes ovatusin Shizuoka, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1994.TB01798.X

Comparison of Borrelia burgdorferi Isolated from Humans and Ixodid Ticks in Hokkaido, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1994.TB01798.X

Current recommendations for the treatment of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1994.TB01798.X

The Spirochetal Etiology of Lyme Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1994.TB01798.X

10.1111/J.1348-0421.1994.TB01798.X

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference